Skip to main content
. 2014 Nov 30;401(1):107–114. doi: 10.1007/s11010-014-2297-7

Table 1.

The inhibitory effect of norfloxacin and moxifloxacin on mushroom tyrosinase activity

Analyzed drug Inhibition ± S.E.Ma (%) ICb50 (mM)
Norfloxacin 0.005 mM 77.3 ± 3.4 0.70
Norfloxacin 0.05 mM 67.7 ± 2.1
Norfloxacin 0.5 mM 53.4 ± 2.3
Norfloxacin 1.0 mM 44.7 ± 3.6
Moxifloxacin 0.005 mM 76.6 ± 1.3 1.20
Moxifloxacin 0.05 mM 70.9 ± 1.7
Moxifloxacin 0.5 mM 61.8 ± 3.1
Moxifloxacin 1.0 mM 56.1 ± 2.5

aSamples-contained phosphate buffer with different norfloxacin or moxifloxacin concentrations, mushroom tyrosinase (1,000 units), and L-DOPA solution (2 mg/ml). Tyrosinase activity was measured as described in “Materials and methods” section

b50 % inhibitory concentration